The U.S. Food and Drug Administration (FDA) has approved paforacyanin (Cytalux) as an injectable contrast agent for adults with lung cancer. of new approvalGranted following priority...
BARCELONA — A new blood test developed by Dutch researchers can identify changes in serum proteins that signal onset. breast cancer Up to 2 years prior...
The results of a large British trial of more than 200,000 women followed for a median of 16 years turned out to be negative. Researchers Ovarian...
Recent Comments